Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters.
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Intracranial Tumor
Both
Intracranial Tumor
Trial Information
Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters.
Inclusion Criteria:
- Age 18 years or older
- Suspected primary brain tumor, verified glioblastoma or non surgically treated
metastases from solid tumor
- Increasing MRI changes in patients with previous verified glioblastoma
- Be able to speak Swedish without difficulties (because of the neuropsychological
investigations)
- Written informed concent
Exclusion Criteria:
- Unability to perform MRI
Type of Study:
Interventional
Study Design:
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Early prediction of treatment response based on MRI parameters.
Outcome Time Frame:
Three weeks compared to baseline.
Safety Issue:
No
Principal Investigator
Danielle van Westen, MD. PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Skåne University Hospital-Lund
Authority:
Sweden: Institutional Review Board
Study ID:
Version1.0
NCT ID:
NCT01674582
Start Date:
October 2012
Completion Date:
February 2015
Related Keywords:
- Intracranial Tumor
- Glioma
- Brain tumors
- Brain metastases
- MRI
- Cognitive measurement
- Neuropsychological evaluation
- DW-MRI
- P-MRI
- MRS
- Brain Neoplasms
Name | Location |
|---|
